Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang
14 Sep 2023 //
BUSINESSWIRE
Chong Kun Dang Pharm Licenses Synaffix ADC Technology
06 Feb 2023 //
PR NEWSWIRE
Chong Kun Dang to export anemia biosim Nesbell to Middle East
05 Jul 2021 //
KOREABIOMED
Chong Kun Dang proceeds to phase 2 trial in Russia to treat COVID-19
01 Sep 2020 //
KOREAN HERALD
OSE Immunotherapeutics inks licensing deal with Chong Kun Dang Pharma
11 Nov 2019 //
BIOSPECTRUM ASIA